Basic pharmacology of new long-acting sympathomimetics Claes-Göran Löfdahl Basic Aspects Of Asthma Pages: 18 - 21
Long-term studies on long-acting sympathomimetics Sven Larsson Basic Aspects Of Asthma Pages: 22 - 24
Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels Thomas F. Lüscher Endothelium- And Epithelium-Derived Relaxing And Contracting Factors Pages: 27 - 34
Endothelium-derived relaxing factors and the human pulmonary circulation D. McCormack Endothelium- And Epithelium-Derived Relaxing And Contracting Factors Pages: 35 - 42
Heterogeneity in epithelium-dependent responses K. Stuart-Smith Endothelium- And Epithelium-Derived Relaxing And Contracting Factors Pages: 43 - 48
Definition and assessment of asthma H. Matthys Formoterol: A New Generation Of β2-Agonists Pages: 51 - 56
The role of neurotransmitters in bronchial asthma Peter J. Barnes Formoterol: A New Generation Of β2-Agonists Pages: 57 - 65
Bronchial asthma and the role ofβ 2-agonists G. M. Cochrane Formoterol: A New Generation Of β2-Agonists Pages: 66 - 70
Characteristics of bronchodilating activity of formoterol A. M. Clauzel Formoterol: A New Generation Of β2-Agonists Pages: 71 - 75
Long-term efficacy of formoterol compared to salbutamol P. R. HekkingF. MaesenP. Zweers Formoterol: A New Generation Of β2-Agonists Pages: 76 - 82
Multicenter 1-year trial on formoterol, a new long-actingβ 2-agonist, in chronic obstructive airway disease G. Schultze-Werninghaus Formoterol: A New Generation Of β2-Agonists Pages: 83 - 89
Efficacy of formoterol metered aerosol in children A. von BergD. Berdel Formoterol: A New Generation Of β2-Agonists Pages: 90 - 98
Formoterol, a new long-acting selectiveβ 2-agonist, decreases airway responsiveness in children with asthma Allan B. BeckerF. EstelleR. Simons Formoterol: A New Generation Of β2-Agonists Pages: 99 - 102
The current place ofβ 2-agonists in the management of asthma Nils Svedmyr A New Perspective Of Asthma Therapy: Salmeterol Pages: 105 - 110
Approaches to a long-acting, selectiveβ 2-adrenoceptor stimulant R. T. Brittain A New Perspective Of Asthma Therapy: Salmeterol Pages: 111 - 114
The pharmacology of salmeterol M. Johnson A New Perspective Of Asthma Therapy: Salmeterol Pages: 115 - 119
Decreased neutral endopeptidases: Possible role in inflammatory diseases of airways Jay A. Nadel Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 123 - 127
Effect of antiasthma drugs on asthmatic reactions induced by toluene diisocyanate in sensitized subjects Leonardo M. Fabbri Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 128 - 131
Pharmacology of airway inflammation in asthma K. F. Chung Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 132 - 141
Long-term drug treatment of asthma in children K. F. Kerrebijn Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 142 - 153
Long-term management of reversible obstructive airways disease in adults Alain LurieFotis D. VlastosJean Marsac Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 154 - 167
Risk/benefit ratio of long-term treatment withβ 2-adrenoceptor agonists Irwin Ziment Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents Pages: 168 - 176
β-Agonistic properties of tulobuterol, a newβ-sympathicomimetic Drug, and its effects on pulmonaryβ-adrenoceptor characteristics G. K. TerpstraJ. A. M. Raaijmakers Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 179 - 185
Can a newβ 2-agonist reduce the mortality of asthma? P. M. Aldons Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 186 - 191
Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma K. H. RühleP. DorowH. Schmitz-Schumann Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 192 - 193
Acute and long-term effectiveness of tulobuterol inhaler, a newβ 2-agonist, in the treatment of asthma D. Charpin Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 194 - 201
Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease K. Werdermann Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 202 - 209
Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis K. R. Patel Systemic And Topical Treatment Of Asthma With An Intrinsically Long-Acting β2-Bronchodilator Pages: 210 - 218
The pharmacology of airway hyperresponsiveness and inflammation R. Pauwels The Role Of Inflammatory Processes In Airway Hyperresponsiveness: Implications For Treatment Pages: 221 - 229
A placebo-controlled blinded comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma K. -Ch. BergmannC. P. BauerA. Overlack The Role Of Inflammatory Processes In Airway Hyperresponsiveness: Implications For Treatment Pages: 230 - 239
Treatment considerations in children aged 0–5 years Peter König Management Of Asthma: A Consensus Report Of Pediatricians Pages: 243 - 245
Determinants and regulating processes in bronchial hyperreactivity H. J. Neijens Asthma In Children Pages: 268 - 277
The progressive nature of childhood asthma F. M. de BenedictisG. J. CannyH. Levison Asthma In Children Pages: 278 - 285
The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease K. R. Chapman The Role Of Anticholinergic Bronchodilator Therapy In Children And Adults Pages: 295 - 303
The role of anticholinergic antimuscarinic bronchodilator therapy in children Michael Silverman The Role Of Anticholinergic Bronchodilator Therapy In Children And Adults Pages: 304 - 309
Passive smoking in childhood—Tobacco smoke Roberto RonchettiEnea BonciFernando D. Martinez Risk Of Smoking In Children Pages: 313 - 319
Prevention of smoking in young children in Holland: Education and changing attitudes B. Baan Risk Of Smoking In Children Pages: 320 - 326
Prevention of pediatric pulmonary problems: The importance of maternal smoking Brent Taylor Risk Of Smoking In Children Pages: 327 - 332
Airways and air pollution in childhood: State of the art Toke Hoppenbrouwers Airways And Air Pollution In Childhood Pages: 335 - 346
Significant association between outdoor NO2 and respiratory symptoms in preschool children M. RutishauserU. AckermannH. U. Wanner Airways And Air Pollution In Childhood Pages: 347 - 352
Air pollution and pediatric respiratory disease: Croup Maximilian Zach Airways And Air Pollution In Childhood Pages: 353 - 357
Environmental findings and sudden infant death syndrome R. G. CarpenterAngela Gardner Airways And Air Pollution In Childhood Pages: 358 - 367
Ciliary activity and pollution Mogens Pedersen Airways And Air Pollution In Childhood Pages: 368 - 376
Development of local immunity: Role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections David NadalPearay L. Ogra Viral Bronchiolitis In Infancy Pages: 379 - 387
